Review



mouse monoclonal antibody against beta actin  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Santa Cruz Biotechnology mouse monoclonal antibody against beta actin
    Mouse Monoclonal Antibody Against Beta Actin, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 47355 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+antibodies+against+beta+actin/%CE%B2-Actin+Antibody/pm41832353-244-5-10
    Average 96 stars, based on 47355 article reviews
    mouse monoclonal antibody against beta actin - by Bioz Stars, 2026-11
    96/100 stars

    Images

    Related Articles

    Bioprocessing:

    Article Title: Cytoskeleton Structure in Mouse Sperm and Testes After 30 Days of Hindlimb Unloading and 12 Hours of Recovery.
    Article Snippet: .. The following specific primary monoclonal antibodies were used at the dilutions recommended by the manufacturers to determine the expression levels of each protein: rabbit antibodies against JARID1B (KDM5B) diluted 1:100 (Bioss Antibodies, Woburn, MA), protamine diluted 1:250 (Sigma-Aldrich, Darmstadt, Germany), and SPACA3 diluted 1:1000 (OriGene, Rockville, MD); and mouse antibodies against beta-actin diluted 1:300, gamma-actin diluted 1:100, alpha-actinin-1 diluted 1:100, alpha-actinin-4 diluted 1:100, and beta-tubulin diluted 1:100 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA). .. Biotinylated goat antibodies were used as the secondary antibodies to detect rabbit IgG (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) and mouse IgG (Sigma-Aldrich) at dilutions of 1:10, 000 and 1:20, 000, respectively.

    Article Title: Cytoskeleton structure and total methylation of mouse cardiac and lung tissue during space flight
    Article Snippet: .. The following specific primary monoclonal antibodies were used at the dilutions recommended by the manufacturers to determine the levels of each protein: mouse antibodies against beta-actin (diluted 1:300), gamma-actin (diluted 1:100), alpha-actinin-1 (diluted 1:100), alpha-actinin-4 (diluted1:100), desmin (diluted 1:300) (Santa Cruz Biotechnology, Inc., USA), and rabbit antibodies against beta-tubulin (diluted 1:1000) (Pierce Thermo Scientific, Inc., USA). .. Biotinylated goat antibodies were used as the secondary antibodies to detect rabbit IgG (Jackson ImmunoResearch Lab, Inc., USA) at a dilution of 1:10,000; to detect mouse IgG (Sigma, Germany), the secondary antibodies were used at a dilution of 1:20,000.

    Expressing:

    Article Title: Cytoskeleton Structure in Mouse Sperm and Testes After 30 Days of Hindlimb Unloading and 12 Hours of Recovery.
    Article Snippet: .. The following specific primary monoclonal antibodies were used at the dilutions recommended by the manufacturers to determine the expression levels of each protein: rabbit antibodies against JARID1B (KDM5B) diluted 1:100 (Bioss Antibodies, Woburn, MA), protamine diluted 1:250 (Sigma-Aldrich, Darmstadt, Germany), and SPACA3 diluted 1:1000 (OriGene, Rockville, MD); and mouse antibodies against beta-actin diluted 1:300, gamma-actin diluted 1:100, alpha-actinin-1 diluted 1:100, alpha-actinin-4 diluted 1:100, and beta-tubulin diluted 1:100 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA). .. Biotinylated goat antibodies were used as the secondary antibodies to detect rabbit IgG (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) and mouse IgG (Sigma-Aldrich) at dilutions of 1:10, 000 and 1:20, 000, respectively.



    Similar Products

    97
    Proteintech mouse monoclonal antibody against β actin
    Effects of PYGL or G6PD silencing on target protein expression and wound closure in HNSCC cells. (A) Western blots of G6PD (59 kDa) and PYGL (97 kDa) in TU686 and SCC25 cells transfected with negative-control small interfering RNA (Control), siG6PD, or siPYGL. <t>β-actin</t> (42 kDa) was used as the loading control. (B) Target protein expression normalized to β-actin and Control. Data are mean ± standard deviation, and dots represent independent experiments. Two-sided paired t-test p values respectively were 0.0215, 0.0091, 0.0299, and 0.0437 for TU686 G6PD, TU686 PYGL, SCC25 G6PD, and SCC25 PYGL. (C) Wound-healing images obtained at 0 and 12 h. Red tracings indicate the wound boundaries. Scale bar, 500 μm. (D) Relative wound closure at 12 h (mean ± standard deviation). One-way analysis of variance with Dunnett correction compared each knockdown with Control. Adjusted p values were 0.0424 (siG6PD) and 0.0078 (siPYGL) in TU686 cells and < 0.0001 for both comparisons in SCC25 cells. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
    Mouse Monoclonal Antibody Against β Actin, supplied by Proteintech, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+antibodies+against+beta+actin/beta+Actin+Monoclonal+antibody/pmc13686788-330-1-9
    Average 97 stars, based on 1 article reviews
    mouse monoclonal antibody against β actin - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    95
    Boster Bio mouse antibody against β actin
    Overexpression of BPGM inhibits tumor metastasis in vitro and in vivo . (A) Silencing BPGM promoted migration of tumor cells. Tumor cells stably expressing shBPGM and its control cells (shCtrl) were examined. Scale bar, 200 μm. (B) Overexpressing BPGM suppressed migration of tumor cells. Tumor cells stably expressing BPGM and its control cells (Ctrl) were examined. Scale bar, 200 μm. (C) The mRNA levels of MMP2 and MMP9 reduced in BPGM-overexpressing tumor cells. SK-HEP-1 cells stably expressing BPGM (BPGM-OE) and its ctrl cells were employed to detect the mRNA levels of MMP2 and MMP9 by qPCR analysis. <t>β-actin</t> was used as an internal control. (D-E) Xenografts of stable Bpgm-overexpressing cells displayed a lower rate of liver and lung metastasis and less metastatic nodules in the liver. For (D), Hepa-Ctrl ( n = 7) and Hepa-BPGM sublines ( n = 6) were inoculated under the capsule of the left hepatic lobe of C57BL/6 mice. Upper panel, a schematic diagram of orthotopic hepatic implantation model. The number of metastatic rate and nodules is shown (D, lower panel). Scale bar, 1 cm. Hematoxylin-eosin staining was performed on serial sections of livers (E, left panel) and lungs (E, right panel) to detect the metastatic nodules. The red arrows indicated the metastatic nodules. Scale bar in left panel, 200 µm; Scale bar in right panel, 100 μm. (F-H) Overexpressing of BPGM inhibited lung metastasis of tumor xenografts. Scale bar in F, 1 cm. B16-F10 cells transfected with Ctrl ( n = 6) or BPGM-OE ( n = 6) was injected into the tail vein of C57BL/6 mice, respectively. Upper panel in F, a schematic diagram of lung metastasis model by tail vein injection. H&E staining of lung sections was performed to observe metastatic foci (G). For G, scale bar in left panel, 500 μm; scale bar in right panel, 200 μm. The number of melanoma nodules and lung metastasis is shown in H. (I) The model deciphers the inhibitory role of BPGM in tumor metastasis. Error bar: mean ± SEM. P -values are labeled above the bar chart.
    Mouse Antibody Against β Actin, supplied by Boster Bio, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+antibodies+against+beta+actin/Anti-beta+Actin+Mouse+Monoclonal+Antibody/pmc13049432-112-4-9
    Average 95 stars, based on 1 article reviews
    mouse antibody against β actin - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    Sino Biological antibodies against β actin
    Overexpression of BPGM inhibits tumor metastasis in vitro and in vivo . (A) Silencing BPGM promoted migration of tumor cells. Tumor cells stably expressing shBPGM and its control cells (shCtrl) were examined. Scale bar, 200 μm. (B) Overexpressing BPGM suppressed migration of tumor cells. Tumor cells stably expressing BPGM and its control cells (Ctrl) were examined. Scale bar, 200 μm. (C) The mRNA levels of MMP2 and MMP9 reduced in BPGM-overexpressing tumor cells. SK-HEP-1 cells stably expressing BPGM (BPGM-OE) and its ctrl cells were employed to detect the mRNA levels of MMP2 and MMP9 by qPCR analysis. <t>β-actin</t> was used as an internal control. (D-E) Xenografts of stable Bpgm-overexpressing cells displayed a lower rate of liver and lung metastasis and less metastatic nodules in the liver. For (D), Hepa-Ctrl ( n = 7) and Hepa-BPGM sublines ( n = 6) were inoculated under the capsule of the left hepatic lobe of C57BL/6 mice. Upper panel, a schematic diagram of orthotopic hepatic implantation model. The number of metastatic rate and nodules is shown (D, lower panel). Scale bar, 1 cm. Hematoxylin-eosin staining was performed on serial sections of livers (E, left panel) and lungs (E, right panel) to detect the metastatic nodules. The red arrows indicated the metastatic nodules. Scale bar in left panel, 200 µm; Scale bar in right panel, 100 μm. (F-H) Overexpressing of BPGM inhibited lung metastasis of tumor xenografts. Scale bar in F, 1 cm. B16-F10 cells transfected with Ctrl ( n = 6) or BPGM-OE ( n = 6) was injected into the tail vein of C57BL/6 mice, respectively. Upper panel in F, a schematic diagram of lung metastasis model by tail vein injection. H&E staining of lung sections was performed to observe metastatic foci (G). For G, scale bar in left panel, 500 μm; scale bar in right panel, 200 μm. The number of melanoma nodules and lung metastasis is shown in H. (I) The model deciphers the inhibitory role of BPGM in tumor metastasis. Error bar: mean ± SEM. P -values are labeled above the bar chart.
    Antibodies Against β Actin, supplied by Sino Biological, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+antibodies+against+beta+actin/beta-Actin+Loading+Control+Antibody%2C+Mouse+MAb/10__1186_slash_s40001___026___04281___4-99-22-26
    Average 95 stars, based on 1 article reviews
    antibodies against β actin - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology mouse monoclonal antibody against beta actin
    Overexpression of BPGM inhibits tumor metastasis in vitro and in vivo . (A) Silencing BPGM promoted migration of tumor cells. Tumor cells stably expressing shBPGM and its control cells (shCtrl) were examined. Scale bar, 200 μm. (B) Overexpressing BPGM suppressed migration of tumor cells. Tumor cells stably expressing BPGM and its control cells (Ctrl) were examined. Scale bar, 200 μm. (C) The mRNA levels of MMP2 and MMP9 reduced in BPGM-overexpressing tumor cells. SK-HEP-1 cells stably expressing BPGM (BPGM-OE) and its ctrl cells were employed to detect the mRNA levels of MMP2 and MMP9 by qPCR analysis. <t>β-actin</t> was used as an internal control. (D-E) Xenografts of stable Bpgm-overexpressing cells displayed a lower rate of liver and lung metastasis and less metastatic nodules in the liver. For (D), Hepa-Ctrl ( n = 7) and Hepa-BPGM sublines ( n = 6) were inoculated under the capsule of the left hepatic lobe of C57BL/6 mice. Upper panel, a schematic diagram of orthotopic hepatic implantation model. The number of metastatic rate and nodules is shown (D, lower panel). Scale bar, 1 cm. Hematoxylin-eosin staining was performed on serial sections of livers (E, left panel) and lungs (E, right panel) to detect the metastatic nodules. The red arrows indicated the metastatic nodules. Scale bar in left panel, 200 µm; Scale bar in right panel, 100 μm. (F-H) Overexpressing of BPGM inhibited lung metastasis of tumor xenografts. Scale bar in F, 1 cm. B16-F10 cells transfected with Ctrl ( n = 6) or BPGM-OE ( n = 6) was injected into the tail vein of C57BL/6 mice, respectively. Upper panel in F, a schematic diagram of lung metastasis model by tail vein injection. H&E staining of lung sections was performed to observe metastatic foci (G). For G, scale bar in left panel, 500 μm; scale bar in right panel, 200 μm. The number of melanoma nodules and lung metastasis is shown in H. (I) The model deciphers the inhibitory role of BPGM in tumor metastasis. Error bar: mean ± SEM. P -values are labeled above the bar chart.
    Mouse Monoclonal Antibody Against Beta Actin, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+antibodies+against+beta+actin/%CE%B2-Actin+Antibody/pm41832353-244-5-10
    Average 96 stars, based on 1 article reviews
    mouse monoclonal antibody against beta actin - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    LI-COR monoclonal mouse antibody against β actin
    Overexpression of BPGM inhibits tumor metastasis in vitro and in vivo . (A) Silencing BPGM promoted migration of tumor cells. Tumor cells stably expressing shBPGM and its control cells (shCtrl) were examined. Scale bar, 200 μm. (B) Overexpressing BPGM suppressed migration of tumor cells. Tumor cells stably expressing BPGM and its control cells (Ctrl) were examined. Scale bar, 200 μm. (C) The mRNA levels of MMP2 and MMP9 reduced in BPGM-overexpressing tumor cells. SK-HEP-1 cells stably expressing BPGM (BPGM-OE) and its ctrl cells were employed to detect the mRNA levels of MMP2 and MMP9 by qPCR analysis. <t>β-actin</t> was used as an internal control. (D-E) Xenografts of stable Bpgm-overexpressing cells displayed a lower rate of liver and lung metastasis and less metastatic nodules in the liver. For (D), Hepa-Ctrl ( n = 7) and Hepa-BPGM sublines ( n = 6) were inoculated under the capsule of the left hepatic lobe of C57BL/6 mice. Upper panel, a schematic diagram of orthotopic hepatic implantation model. The number of metastatic rate and nodules is shown (D, lower panel). Scale bar, 1 cm. Hematoxylin-eosin staining was performed on serial sections of livers (E, left panel) and lungs (E, right panel) to detect the metastatic nodules. The red arrows indicated the metastatic nodules. Scale bar in left panel, 200 µm; Scale bar in right panel, 100 μm. (F-H) Overexpressing of BPGM inhibited lung metastasis of tumor xenografts. Scale bar in F, 1 cm. B16-F10 cells transfected with Ctrl ( n = 6) or BPGM-OE ( n = 6) was injected into the tail vein of C57BL/6 mice, respectively. Upper panel in F, a schematic diagram of lung metastasis model by tail vein injection. H&E staining of lung sections was performed to observe metastatic foci (G). For G, scale bar in left panel, 500 μm; scale bar in right panel, 200 μm. The number of melanoma nodules and lung metastasis is shown in H. (I) The model deciphers the inhibitory role of BPGM in tumor metastasis. Error bar: mean ± SEM. P -values are labeled above the bar chart.
    Monoclonal Mouse Antibody Against β Actin, supplied by LI-COR, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+antibodies+against+beta+actin/BETA-ACTIN+MOUSE+mAb/pmc12934295-196-1-6
    Average 96 stars, based on 1 article reviews
    monoclonal mouse antibody against β actin - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    98
    ABclonal Biotechnology antibody against β actin ac004
    Overexpression of BPGM inhibits tumor metastasis in vitro and in vivo . (A) Silencing BPGM promoted migration of tumor cells. Tumor cells stably expressing shBPGM and its control cells (shCtrl) were examined. Scale bar, 200 μm. (B) Overexpressing BPGM suppressed migration of tumor cells. Tumor cells stably expressing BPGM and its control cells (Ctrl) were examined. Scale bar, 200 μm. (C) The mRNA levels of MMP2 and MMP9 reduced in BPGM-overexpressing tumor cells. SK-HEP-1 cells stably expressing BPGM (BPGM-OE) and its ctrl cells were employed to detect the mRNA levels of MMP2 and MMP9 by qPCR analysis. <t>β-actin</t> was used as an internal control. (D-E) Xenografts of stable Bpgm-overexpressing cells displayed a lower rate of liver and lung metastasis and less metastatic nodules in the liver. For (D), Hepa-Ctrl ( n = 7) and Hepa-BPGM sublines ( n = 6) were inoculated under the capsule of the left hepatic lobe of C57BL/6 mice. Upper panel, a schematic diagram of orthotopic hepatic implantation model. The number of metastatic rate and nodules is shown (D, lower panel). Scale bar, 1 cm. Hematoxylin-eosin staining was performed on serial sections of livers (E, left panel) and lungs (E, right panel) to detect the metastatic nodules. The red arrows indicated the metastatic nodules. Scale bar in left panel, 200 µm; Scale bar in right panel, 100 μm. (F-H) Overexpressing of BPGM inhibited lung metastasis of tumor xenografts. Scale bar in F, 1 cm. B16-F10 cells transfected with Ctrl ( n = 6) or BPGM-OE ( n = 6) was injected into the tail vein of C57BL/6 mice, respectively. Upper panel in F, a schematic diagram of lung metastasis model by tail vein injection. H&E staining of lung sections was performed to observe metastatic foci (G). For G, scale bar in left panel, 500 μm; scale bar in right panel, 200 μm. The number of melanoma nodules and lung metastasis is shown in H. (I) The model deciphers the inhibitory role of BPGM in tumor metastasis. Error bar: mean ± SEM. P -values are labeled above the bar chart.
    Antibody Against β Actin Ac004, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+antibodies+against+beta+actin/ACTB+Mouse+mAb/pm41692347-56-0-7
    Average 98 stars, based on 1 article reviews
    antibody against β actin ac004 - by Bioz Stars, 2026-11
    98/100 stars
      Buy from Supplier

    93
    Cusabio mouse monoclonal antibody against b actin
    Overexpression of BPGM inhibits tumor metastasis in vitro and in vivo . (A) Silencing BPGM promoted migration of tumor cells. Tumor cells stably expressing shBPGM and its control cells (shCtrl) were examined. Scale bar, 200 μm. (B) Overexpressing BPGM suppressed migration of tumor cells. Tumor cells stably expressing BPGM and its control cells (Ctrl) were examined. Scale bar, 200 μm. (C) The mRNA levels of MMP2 and MMP9 reduced in BPGM-overexpressing tumor cells. SK-HEP-1 cells stably expressing BPGM (BPGM-OE) and its ctrl cells were employed to detect the mRNA levels of MMP2 and MMP9 by qPCR analysis. <t>β-actin</t> was used as an internal control. (D-E) Xenografts of stable Bpgm-overexpressing cells displayed a lower rate of liver and lung metastasis and less metastatic nodules in the liver. For (D), Hepa-Ctrl ( n = 7) and Hepa-BPGM sublines ( n = 6) were inoculated under the capsule of the left hepatic lobe of C57BL/6 mice. Upper panel, a schematic diagram of orthotopic hepatic implantation model. The number of metastatic rate and nodules is shown (D, lower panel). Scale bar, 1 cm. Hematoxylin-eosin staining was performed on serial sections of livers (E, left panel) and lungs (E, right panel) to detect the metastatic nodules. The red arrows indicated the metastatic nodules. Scale bar in left panel, 200 µm; Scale bar in right panel, 100 μm. (F-H) Overexpressing of BPGM inhibited lung metastasis of tumor xenografts. Scale bar in F, 1 cm. B16-F10 cells transfected with Ctrl ( n = 6) or BPGM-OE ( n = 6) was injected into the tail vein of C57BL/6 mice, respectively. Upper panel in F, a schematic diagram of lung metastasis model by tail vein injection. H&E staining of lung sections was performed to observe metastatic foci (G). For G, scale bar in left panel, 500 μm; scale bar in right panel, 200 μm. The number of melanoma nodules and lung metastasis is shown in H. (I) The model deciphers the inhibitory role of BPGM in tumor metastasis. Error bar: mean ± SEM. P -values are labeled above the bar chart.
    Mouse Monoclonal Antibody Against B Actin, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+antibodies+against+beta+actin/Mouse+anti-Beta-Actin+Monoclonal+Antibody/pm41574549-102-11-17
    Average 93 stars, based on 1 article reviews
    mouse monoclonal antibody against b actin - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    Image Search Results


    Effects of PYGL or G6PD silencing on target protein expression and wound closure in HNSCC cells. (A) Western blots of G6PD (59 kDa) and PYGL (97 kDa) in TU686 and SCC25 cells transfected with negative-control small interfering RNA (Control), siG6PD, or siPYGL. β-actin (42 kDa) was used as the loading control. (B) Target protein expression normalized to β-actin and Control. Data are mean ± standard deviation, and dots represent independent experiments. Two-sided paired t-test p values respectively were 0.0215, 0.0091, 0.0299, and 0.0437 for TU686 G6PD, TU686 PYGL, SCC25 G6PD, and SCC25 PYGL. (C) Wound-healing images obtained at 0 and 12 h. Red tracings indicate the wound boundaries. Scale bar, 500 μm. (D) Relative wound closure at 12 h (mean ± standard deviation). One-way analysis of variance with Dunnett correction compared each knockdown with Control. Adjusted p values were 0.0424 (siG6PD) and 0.0078 (siPYGL) in TU686 cells and < 0.0001 for both comparisons in SCC25 cells. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

    Journal: Journal of Cancer

    Article Title: An Eight-Gene Metabolic Prognostic Signature in Head and Neck Squamous Cell Carcinoma: Cross-Cohort Evaluation, Single-Cell Analysis, and Preliminary Functional Evaluation of PYGL and G6PD

    doi: 10.7150/jca.134402

    Figure Lengend Snippet: Effects of PYGL or G6PD silencing on target protein expression and wound closure in HNSCC cells. (A) Western blots of G6PD (59 kDa) and PYGL (97 kDa) in TU686 and SCC25 cells transfected with negative-control small interfering RNA (Control), siG6PD, or siPYGL. β-actin (42 kDa) was used as the loading control. (B) Target protein expression normalized to β-actin and Control. Data are mean ± standard deviation, and dots represent independent experiments. Two-sided paired t-test p values respectively were 0.0215, 0.0091, 0.0299, and 0.0437 for TU686 G6PD, TU686 PYGL, SCC25 G6PD, and SCC25 PYGL. (C) Wound-healing images obtained at 0 and 12 h. Red tracings indicate the wound boundaries. Scale bar, 500 μm. (D) Relative wound closure at 12 h (mean ± standard deviation). One-way analysis of variance with Dunnett correction compared each knockdown with Control. Adjusted p values were 0.0424 (siG6PD) and 0.0078 (siPYGL) in TU686 cells and < 0.0001 for both comparisons in SCC25 cells. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

    Article Snippet: A mouse monoclonal antibody against β-actin (Cat. No. 66009-1-Ig, Proteintech) was used as the loading control.

    Techniques: Expressing, Western Blot, Transfection, Negative Control, Small Interfering RNA, Control, Standard Deviation, Analysis, Knockdown

    Overexpression of BPGM inhibits tumor metastasis in vitro and in vivo . (A) Silencing BPGM promoted migration of tumor cells. Tumor cells stably expressing shBPGM and its control cells (shCtrl) were examined. Scale bar, 200 μm. (B) Overexpressing BPGM suppressed migration of tumor cells. Tumor cells stably expressing BPGM and its control cells (Ctrl) were examined. Scale bar, 200 μm. (C) The mRNA levels of MMP2 and MMP9 reduced in BPGM-overexpressing tumor cells. SK-HEP-1 cells stably expressing BPGM (BPGM-OE) and its ctrl cells were employed to detect the mRNA levels of MMP2 and MMP9 by qPCR analysis. β-actin was used as an internal control. (D-E) Xenografts of stable Bpgm-overexpressing cells displayed a lower rate of liver and lung metastasis and less metastatic nodules in the liver. For (D), Hepa-Ctrl ( n = 7) and Hepa-BPGM sublines ( n = 6) were inoculated under the capsule of the left hepatic lobe of C57BL/6 mice. Upper panel, a schematic diagram of orthotopic hepatic implantation model. The number of metastatic rate and nodules is shown (D, lower panel). Scale bar, 1 cm. Hematoxylin-eosin staining was performed on serial sections of livers (E, left panel) and lungs (E, right panel) to detect the metastatic nodules. The red arrows indicated the metastatic nodules. Scale bar in left panel, 200 µm; Scale bar in right panel, 100 μm. (F-H) Overexpressing of BPGM inhibited lung metastasis of tumor xenografts. Scale bar in F, 1 cm. B16-F10 cells transfected with Ctrl ( n = 6) or BPGM-OE ( n = 6) was injected into the tail vein of C57BL/6 mice, respectively. Upper panel in F, a schematic diagram of lung metastasis model by tail vein injection. H&E staining of lung sections was performed to observe metastatic foci (G). For G, scale bar in left panel, 500 μm; scale bar in right panel, 200 μm. The number of melanoma nodules and lung metastasis is shown in H. (I) The model deciphers the inhibitory role of BPGM in tumor metastasis. Error bar: mean ± SEM. P -values are labeled above the bar chart.

    Journal: Neoplasia (New York, N.Y.)

    Article Title: BPGM as an intrinsic brake to constrain metastasis through phospho-epigenetic-mediated carnitine biosynthesis suppression

    doi: 10.1016/j.neo.2026.101299

    Figure Lengend Snippet: Overexpression of BPGM inhibits tumor metastasis in vitro and in vivo . (A) Silencing BPGM promoted migration of tumor cells. Tumor cells stably expressing shBPGM and its control cells (shCtrl) were examined. Scale bar, 200 μm. (B) Overexpressing BPGM suppressed migration of tumor cells. Tumor cells stably expressing BPGM and its control cells (Ctrl) were examined. Scale bar, 200 μm. (C) The mRNA levels of MMP2 and MMP9 reduced in BPGM-overexpressing tumor cells. SK-HEP-1 cells stably expressing BPGM (BPGM-OE) and its ctrl cells were employed to detect the mRNA levels of MMP2 and MMP9 by qPCR analysis. β-actin was used as an internal control. (D-E) Xenografts of stable Bpgm-overexpressing cells displayed a lower rate of liver and lung metastasis and less metastatic nodules in the liver. For (D), Hepa-Ctrl ( n = 7) and Hepa-BPGM sublines ( n = 6) were inoculated under the capsule of the left hepatic lobe of C57BL/6 mice. Upper panel, a schematic diagram of orthotopic hepatic implantation model. The number of metastatic rate and nodules is shown (D, lower panel). Scale bar, 1 cm. Hematoxylin-eosin staining was performed on serial sections of livers (E, left panel) and lungs (E, right panel) to detect the metastatic nodules. The red arrows indicated the metastatic nodules. Scale bar in left panel, 200 µm; Scale bar in right panel, 100 μm. (F-H) Overexpressing of BPGM inhibited lung metastasis of tumor xenografts. Scale bar in F, 1 cm. B16-F10 cells transfected with Ctrl ( n = 6) or BPGM-OE ( n = 6) was injected into the tail vein of C57BL/6 mice, respectively. Upper panel in F, a schematic diagram of lung metastasis model by tail vein injection. H&E staining of lung sections was performed to observe metastatic foci (G). For G, scale bar in left panel, 500 μm; scale bar in right panel, 200 μm. The number of melanoma nodules and lung metastasis is shown in H. (I) The model deciphers the inhibitory role of BPGM in tumor metastasis. Error bar: mean ± SEM. P -values are labeled above the bar chart.

    Article Snippet: The antibodies used included mouse antibody against β-actin (BM0627, Boster, Wuhan, China), rabbit antibody against BPGM (17173-1-AP, Proteintech), EZH2 (F0281, Selleck), phospho-EZH2 (Thr345) (TA3584S, Abmart, Shanghai, China), phospho-CDK1 (Thr14) (AP1465, Abclonal, Wuhan, China), ubiquitin (10201-2-AP, Proteintech), HIF1α (36169, Cell Signaling Technology, CST, Beverly, MA, USA), H3K4me3 (91264, Active Motif), H3K79me3 (cat 49-1020, Thermos Fisher), H3K9me3 (61014, Active Motif), H3K27me3 (91168, Active Motif) and Histone 3 (F0057, Selleck).

    Techniques: Over Expression, In Vitro, In Vivo, Migration, Stable Transfection, Expressing, Control, Staining, Transfection, Injection, Labeling